Logo image of SRI

STONERIDGE INC (SRI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SRI - US86183P1021 - Common Stock

5.81 USD
0 (0%)
Last: 12/30/2025, 2:41:03 PM
Fundamental Rating

2

Overall SRI gets a fundamental rating of 2 out of 10. We evaluated SRI against 43 industry peers in the Automobile Components industry. While SRI seems to be doing ok healthwise, there are quite some concerns on its profitability. SRI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SRI had negative earnings in the past year.
In the past year SRI had a positive cash flow from operations.
SRI had negative earnings in 4 of the past 5 years.
SRI had a positive operating cash flow in 4 of the past 5 years.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.07%, SRI is doing worse than 67.44% of the companies in the same industry.
SRI's Return On Equity of -12.76% is in line compared to the rest of the industry. SRI outperforms 41.86% of its industry peers.
Industry RankSector Rank
ROA -5.07%
ROE -12.76%
ROIC N/A
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

SRI's Operating Margin has declined in the last couple of years.
The Gross Margin of SRI (20.98%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SRI has declined.
The Profit Margin and Operating Margin are not available for SRI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.98%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

SRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SRI has more shares outstanding
SRI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SRI has a worse debt to assets ratio.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.33 indicates that SRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
SRI's Altman-Z score of 2.33 is in line compared to the rest of the industry. SRI outperforms 55.81% of its industry peers.
The Debt to FCF ratio of SRI is 7.28, which is on the high side as it means it would take SRI, 7.28 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.28, SRI is in the better half of the industry, outperforming 60.47% of the companies in the same industry.
A Debt/Equity ratio of 0.68 indicates that SRI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.68, SRI perfoms like the industry average, outperforming 46.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.28
Altman-Z 2.33
ROIC/WACCN/A
WACC9.93%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 2.13 indicates that SRI has no problem at all paying its short term obligations.
SRI has a Current ratio of 2.13. This is in the better half of the industry: SRI outperforms 62.79% of its industry peers.
SRI has a Quick Ratio of 1.33. This is a normal value and indicates that SRI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.33, SRI is doing good in the industry, outperforming 60.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.33
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

The earnings per share for SRI have decreased strongly by -383.33% in the last year.
The Revenue has decreased by -4.92% in the past year.
The Revenue has been growing slightly by 1.71% on average over the past years.
EPS 1Y (TTM)-383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-4.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-1.67%

3.2 Future

The Earnings Per Share is expected to grow by 22.71% on average over the next years. This is a very strong growth
Based on estimates for the next years, SRI will show a decrease in Revenue. The Revenue will decrease by -0.23% on average per year.
EPS Next Y-125.64%
EPS Next 2Y22.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.47%
Revenue Next 2Y-0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SRI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

SRI's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, SRI is valued cheaper than 93.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.92
EV/EBITDA 10.35
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as SRI's earnings are expected to grow with 22.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.71%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SRI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

STONERIDGE INC

NYSE:SRI (12/30/2025, 2:41:03 PM)

5.81

0 (0%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners86.5%
Inst Owner Change-7.54%
Ins Owners2.26%
Ins Owner Change0%
Market Cap162.80M
Revenue(TTM)874.36M
Net Income(TTM)-32.04M
Analysts84
Price Target16.32 (180.9%)
Short Float %1.19%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.55%
Min Revenue beat(2)1.3%
Max Revenue beat(2)1.8%
Revenue beat(4)3
Avg Revenue beat(4)0.84%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)2.92%
Revenue beat(8)4
Avg Revenue beat(8)-0.51%
Revenue beat(12)7
Avg Revenue beat(12)0.72%
Revenue beat(16)11
Avg Revenue beat(16)3.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-700%
EPS NQ rev (3m)-700%
EPS NY rev (1m)-150%
EPS NY rev (3m)-150%
Revenue NQ rev (1m)-1.88%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)-1.61%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 6.92
P/OCF 3.66
P/B 0.65
P/tB 0.94
EV/EBITDA 10.35
EPS(TTM)-0.87
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.84
FCFY14.45%
OCF(TTM)1.59
OCFY27.29%
SpS31.2
BVpS8.96
TBVpS6.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -12.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.98%
FCFM 2.69%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score5
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.28
Debt/EBITDA 6.29
Cap/Depr 62.27%
Cap/Sales 2.39%
Interest Coverage N/A
Cash Conversion 164.3%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.33
Altman-Z 2.33
F-Score5
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-125.64%
EPS Next 2Y22.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-1.67%
Revenue Next Year-6.47%
Revenue Next 2Y-0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-152.66%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year113.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y295.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.75%
OCF growth 3YN/A
OCF growth 5Y14.27%

STONERIDGE INC / SRI FAQ

What is the fundamental rating for SRI stock?

ChartMill assigns a fundamental rating of 2 / 10 to SRI.


What is the valuation status for SRI stock?

ChartMill assigns a valuation rating of 2 / 10 to STONERIDGE INC (SRI). This can be considered as Overvalued.


How profitable is STONERIDGE INC (SRI) stock?

STONERIDGE INC (SRI) has a profitability rating of 1 / 10.


How financially healthy is STONERIDGE INC?

The financial health rating of STONERIDGE INC (SRI) is 4 / 10.